PPG 51672 Calcipotriene and Betamethasone Dipropionate Topical Suspension

Product Description

PPG 51672 Calcipotriene and Betamethasone Dipropionate Topical Suspension is a prescription topical medicine designed to treat plaque psoriasis. It is suitable for individuals aged twelve and older for scalp treatment, and for adults eighteen years and older for both scalp and body use. This product helps reduce the symptoms associated with psoriasis, offering users an effective way to manage their condition.

• Used to treat plaque psoriasis of the scalp in people 12 years and older
• Used to treat plaque psoriasis of the scalp and body in people 18 years and older
• Contains calcipotriene hydrate and betamethasone dipropionate

Product Highlights

This topical suspension combines two effective ingredients to assist in the management of plaque psoriasis.

Product Information

Standard Information

• Dosage Form: Topical Suspension
• Recommended Age: 12 years and older

Technical Specifications

• Active Ingredients: Calcipotriene (50 mcg) and Betamethasone Dipropionate (0.643 mg) per gram
• Calcipotriene Hydrate Chemical Name: 9,10-secochola-5,7,10(19),22-tetraene-1,3,24-triol,24-cyclopropyl-,monohydrate
• Betamethasone Dipropionate Chemical Name: pregna-1,4-diene-3,20-dione-9-fluoro-11hydroxy-16-methyl-17,21-bis(1-oxypropoxy)
• Weight: 1 pound